The attempt to address the most menacing threat faced by mankind finds a hope. At Bugworks, our world class team aims to create a much needed respite to AMR through our broad spectrum anti-bacterial assets.
Saving mankind from the threat of AMR using our path-breaking discoveries
Know More
Bugworks Research Inc. CSO Dr. Santanu Datta underscores need for a Bayh-Dole like Act to propel research commercialization
Bugworks Research starts first human dose study to treat critical bacterial infections - ETHealthWorld
Bugworks Research begins first in human phase 1 study of BWC0977 to treat critical bacterial infections
Indian innovation at work: Bugworks embarks on phase I trials in its pursuit for a new antibiotic
